Skip to main content
Premium Trial:

Request an Annual Quote

Downloads and Upgrades: Human CCDS 15 and NEBioCalculator


The National Center for Biotechnology has released a Consensus Coding Sequence update for Homo sapiens annotation release 105. The update is available on the CCDS website and via FTP.

The release adds 349 new CCDS IDs to the human CCDS dataset and is based on comparative analysis of NCBI Homo sapiens annotation release 105 and Ensembl release 74. The human CCDS dataset now includes 29,045 proteins that correspond to 18,683 genes.

New England Biolabs has released NEBioCalculator, a collection of web-based calculators and converters that are useful in planning bench experiments in molecular biology laboratories.

The NEBioCalculator supports molarity calculation, OD260 conversion, ligation calculation, and mass/moles conversion for both dsDNA and ssRNA, and more. It provides calculations based on user-specified units. Scientists can input their measurements in milligram, microgram, nanogram or picogram amounts, leading to accurate calculations that require no further conversion.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.